NAV
25.76(-0.19%)Fund Size (CR)
₹1,010.54Expense Ratio
1.01Scheme Type
Active FundValue Research
-
Min. investment
₹1,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹10Minimum Withdrawal
₹1Exit Load
1%Return Since Launch
21.38%
Basic Details
Scheme Manager
Dhaval Shah
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | July 17, 2026 | 10035.07 | 0.35% | - | -1.37% | 37/1007 |
| 1 Month | June 24, 2026 | 10353.72 | 3.54% | - | -0.03% | 49/1007 |
| 3 Month | April 24, 2026 | 11515.42 | 15.15% | - | 4.23% | 26/1007 |
| 6 Month | January 23, 2026 | 12147.72 | 21.48% | - | 6.97% | 60/964 |
| 1 Year | July 24, 2025 | 11399.54 | 14.00% | 14.00% | 3.97% | 77/902 |
| 3 Year | July 24, 2023 | 18546.69 | 85.47% | 22.84% | 15.27% | 46/544 |
| 5 Year | July 23, 2021 | 19558.74 | 95.59% | 14.34% | 13.70% | 172/442 |
| Since Inception | July 11, 2019 | 39124.48 | 291.24% | 21.38% | 11.36% | 71/1007 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | August 1, 2025 | 1,20,000 | 202458.21 | 68.72% | 68.72% |
| 3 Year | August 1, 2023 | 3,60,000 | 652184.37 | 81.16% | 21.91% |
| 5 Year | August 2, 2021 | 6,00,000 | 1256551.74 | 109.43% | 15.93% |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Risk Ratios
4.53%
Standard Deviation
0.65%
Beta
1.09%
Sharpe Ratio
0.09%
Treynor's Ratio
16.48%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 12.09% | 656076 | 122.19 | Equity | Pharmaceuticals |
| Apollo Hospitals | 7.30% | 84936 | 73.74 | Equity | Healthcare |
| J B Chemicals & | 4.71% | 207484 | 47.64 | Equity | Pharmaceuticals |
| Torrent Pharma. | 4.68% | 102446 | 47.33 | Equity | Pharmaceuticals |
| Aurobindo Pharma | 4.55% | 291254 | 45.98 | Equity | Pharmaceuticals |
| Ajanta Pharma | 4.38% | 129312 | 44.26 | Equity | Pharmaceuticals |
| Mankind Pharma | 3.92% | 155574 | 39.60 | Equity | Pharmaceuticals |
| Lupin | 3.74% | 156214 | 37.79 | Equity | Pharmaceuticals |
| Sai Life | 3.50% | 286508 | 35.36 | Equity | Pharmaceuticals |
| Abbott India | 3.26% | 12933 | 32.90 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Aditya Birla SL Pharma & Healthcare Fund-Dir(IDCW) | 1010.54 | 3.54% | 15.15% | 21.48% | 14.00% | 22.84% | |
| Nippon India Taiwan Equity Fund - Direct (G) | 1191.72 | -14.28% | -1.85% | 64.97% | 140.70% | 51.87% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 1191.72 | -14.28% | -1.85% | 64.97% | 140.70% | 51.87% | |
| Franklin Asian Equity Fund - Direct (G) | 979.21 | -4.39% | 7.85% | 15.38% | 36.79% | 20.22% | |
| Franklin Asian Equity Fund - Direct (IDCW) | 979.21 | -4.39% | 7.85% | 15.38% | 36.78% | 20.21% | |
| Nippon India Japan Equity Fund - Direct (G) | 332.11 | 1.89% | 8.13% | 16.50% | 29.05% | 20.18% |
List of Schemes under Aditya Birla Sun Life Mutual Fund
News
Aditya Birla Sun Life Mutual Fund announces change in Exit Load Structure
Aditya Birla Sun Life Mutual Fund has announced change in exit load structure under following scheme stands revised with effect from July 27, 2026.Change in Exit Load:
Name of the Scheme Existing Exit Load Revised Exit Load Aditya Birla Sun Life Arbitrage Fund ' For redemption / switch out of units within 15 days from the date of allotment: 0.25% of applicable NAV ' For redemption / switch out of units after 15 days from the date of allotment: Nil
Nil Powered by Capital Market - Live News
Aditya Birla Sun Life MF announces Income Distribution cum Capital Withdrawal (IDCW) under its schemes
Aditya Birla Sun Life Mutual Fund has announced 24 July 2026 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) under the following schemes. The quantum of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:Aditya Birla Sun Life Balanced Advantage Fund:
Regular Plan ' IDCW Option: 0.183
Direct Plan ' IDCW Option: 0.210
Aditya Birla Sun Life Arbitrage Fund:
Regular Plan ' IDCW Option: 0.064
Direct Plan ' IDCW Option: 0.067
Aditya Birla Sun Life Value Fund:
Regular Plan ' IDCW Option: 3.140
Direct Plan ' IDCW Option: 5.779
Aditya Birla Sun Life Focused Fund:
Regular Plan ' IDCW Option: 1.755
Direct Plan ' IDCW Option: 4.172
Aditya Birla Sun Life Digital India Fund:
Regular Plan ' IDCW Option: 2.608
Direct Plan ' IDCW Option: 3.583
Aditya Birla Sun Life Equity Hybrid 95 Fund:
Regular Plan ' IDCW Option: 3.009
Direct Plan ' IDCW Option: 5.179
Powered by Capital Market - Live News
Aditya Birla Sun Life Fixed Term Plan ' Series TI (1837 days) Merger into Aditya Birla Sun Life Corporate Bond Fund
Aditya Birla Sun Life Mutual Fund has approved the merger of Aditya Birla Sun Life Fixed Term Plan ' Series TI (1837 days) Merger into Aditya Birla Sun Life Corporate Bond Fund, with effect from 09 July 2026.Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
June 20, 2019
Total AUM (Cr)
₹1010.54
Aditya Birla SL Pharma & Healthcare Fund-Dir(IDCW) is an Sectoral / Thematic-oriented fund from the renowned AMC, Aditya Birla Sun Life Mutual Fund. Launched in June 20, 2019, this fund is managed by Dhaval Shah. With assets under management (AUM) worth ₹1,010.54 (Cr), as of July 24, 2026, Aditya Birla SL Pharma & Healthcare Fund-Dir(IDCW) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 21.38% since its launch.
The current NAV of Aditya Birla SL Pharma & Healthcare Fund-Dir(IDCW) is ₹25.76, as on July 24, 2026. The fund's benchmark index is BSE Healthcare TRI. You can invest in Aditya Birla SL Pharma & Healthcare Fund-Dir(IDCW) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹10 while the minimum lumpsum investment is ₹1,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 22.84% and 14.34% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 97.85% in Equity, 2.26% in Debt and -0.11% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 75.08% in Pharmaceuticals & Biotech, 20.09% in Healthcare Services, 3.23% in Debt, 1.01% in Insurance, 0.65% in Chemicals & Petrochemical
Mutual Fund Categories
Types of Mutual Funds
Debt Funds
Access debt markets and enjoy interest income from bonds and debentures. Ideal for conservative short-term investors
Hybrid Funds
Enjoy best of both the worlds - equity and debt. Ideal for beginners with medium-term investment horizon
Equity Funds
Invest in large, mid, and small cap sector stocks to enjoy capital appreciation. Ideal for aggressive, long-term investors
